Roland E. Kontermann
Stuttgart, BW 70174, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 125 publications
Novel bispecific T-cell engagers overcoming acquired EGFR resistance.
Journal: mAbs
Published: May 19, 2026
Protein engineering: status report.
Journal: Protein engineering, design & selection : PEDS
Published: February 02, 2026
Protein engineering: Status report.
Journal: Protein engineering, design & selection : PEDS
Published: February 02, 2026
The making of multispecific immunoglobulins - a clinical perspective.
Journal: mAbs
Published: January 16, 2026
Comparative Assessment of Various Formats of TRAIL in Three-Dimensional Cell Culture and Patient-Derived Tumoroids of Colorectal Cancer.
Journal: Journal of oncology research and therapy
Published: October 02, 2025
A pH-sensitive binding modality allows successful transferrin receptor-mediated transcytosis of a bivalent antibody across brain barriers.
Journal: mAbs
Published: September 22, 2025
BCL-xL as a therapeutic target in cetuximab-refractory colorectal cancer.
Journal: Cell death & disease
Published: June 30, 2025
Oncolytic adenoviruses encoding bispecific T cell engagers or a novel trispecific T cell engager for dual-targeting of c-MET and EGFR.
Journal: Molecular therapy. Oncology
Published: June 13, 2025
Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3.
Journal: Frontiers in immunology
Published: June 06, 2025
Immunoliposomes - a new therapeutic option to treat SynGAP1-associated epilepsy.
Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
Published: January 27, 2025
Last Updated: 09/26/2026